Active substance
Trihexyphenidyl
- SFDA 2
- US FDA 18
- Health Canada 2
- US price lines 2
- NHS prices 3
- WHO EML 1
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| ARTANE 2 MG TAB | 2 mg | Tablet · Oral use | 100 Tablet Container | SAR 16.80 | NCE · Prescription | WYETH | Withdrawn by MAH · Not Marketed |
| ARTANE 5 MG TAB | 5 mg | Tablet · Oral use | 100 Tablet Container | SAR 22.20 | NCE · Prescription | WYETH | Withdrawn by MAH · Not Marketed |
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| TRIHEXYPHENIDYL HYDROCHLORIDE | 2MG | tablet · oral | WATSON LABS | Prescription | 26 Nov 1974 |
| TRIHEXYPHENIDYL HYDROCHLORIDE | 5MG | tablet · oral | WATSON LABS | Prescription | 6 Dec 1974 |
| TRIHEXYPHENIDYL HYDROCHLORIDE | 2MG/5ML | elixir · oral | PHARM ASSOC | Prescription | 17 Apr 1997 |
| TRIHEXYPHENIDYL HYDROCHLORIDE | 2MG; 5MG | tablet · oral | NOVITIUM PHARMA | Prescription | 24 Dec 1998 |
| TRIHEXYPHENIDYL HYDROCHLORIDE | 2MG/5ML | elixir · oral | CHARTWELL RX | Prescription | 27 Sep 1999 |
| TRIHEXYPHENIDYL HYDROCHLORIDE | 2MG; 5MG | tablet · oral | NATCO PHARMA LTD | Prescription | 17 Nov 2010 |
| ARTANE | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet · oral | LEDERLE | Discontinued | 13 May 1949 |
| ARTANE | 2MG/5ML | elixir · oral | LEDERLE | Discontinued | 13 May 1949 |
| ARTANE | 5MG | capsule, extended release · oral | LEDERLE | Discontinued | 13 May 1949 |
| ARTANE | 5MG | capsule, extended release · oral | LEDERLE | Discontinued | 18 Apr 1962 |
| TRIHEXYPHENIDYL HYDROCHLORIDE | 2MG | tablet · oral | VANGARD | Discontinued | 30 Jul 1982 |
| TRIHEXYPHENIDYL HYDROCHLORIDE | 2MG/5ML | elixir · oral | PHARM VENTURES | Discontinued | 7 Apr 1989 |
| TRIHEXYPHENIDYL HYDROCHLORIDE | 2MG; 5MG | tablet · oral | WATSON LABS | Discontinued | 6 Feb 1998 |
| TRIHEXYPHENIDYL HYDROCHLORIDE | 5MG; 2MG | tablet · oral | HIKMA | Discontinued | 16 Feb 2000 |
| TREMIN | 2MG; 5MG | tablet · oral | SCHERING | Discontinued | |
| TRIHEXYPHENIDYL HYDROCHLORIDE | 5MG | tablet · oral | WATSON LABS | Discontinued | |
| TRIHEXYPHENIDYL HYDROCHLORIDE | 2MG | tablet · oral | WATSON LABS | Discontinued | |
| TRIHEXYPHENIDYL HYDROCHLORIDE | 5MG | tablet · oral | NYLOS | Discontinued |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| TRIHEXYPHENIDYL | 00545058 | 2 MG | TABLET · ORAL | AA PHARMA INC |
| TRIHEXYPHENIDYL | 00545074 | 5 MG | TABLET · ORAL | AA PHARMA INC |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | TRIHEXYPHENIDYL 2 MG TABLET | $0.08838 | per EA | 23 Sep 2026 |
| US NADAC | TRIHEXYPHENIDYL 5 MG TABLET | $0.1191 | per EA | 23 Sep 2026 |
| NHS Drug Tariff | Trihexyphenidyl 2mg tablets | £142.43 | 84 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Trihexyphenidyl 5mg tablets | £214.94 | 84 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Trihexyphenidyl 5mg/5ml oral solution | £118.41 | 200 ml | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
WHO WHO Model List of Essential Medicines (2025)
- 5.1.3. Medicines for parkinsonism · core
Therapeutic equivalent to biperiden for Parkinson disease
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.